Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Actinium Pharmaceuticals (ATNM) Gains Momentum: Strategic KOL Call Scheduled Amid Radiopharma…
Reason why Investors need to watch Aspen Aerogels (NYSE: ASPN) recent…
CytomX Therapeutics (NASADAQ: CTMX) Revolutionizing Cancer Treatment with Groundbreaking Biologics
Cyclacel Pharmaceuticals (NASDAQ: CYCC) Sees Significant Stock Volatility Amid New Financing…
GeneDx Holdings Corp. (WGS) Bolsters Financial and Strategic Position in 2024
Finance
Actinium Pharmaceuticals (ATNM): Poised for Growth? Targeted Radiotherapy Conditioning Agent Shows…
Biotech Stocks Take Centerstage as Markets Turn Red (COEP,AMLX, BMRN, EXEL,…
S&P 500 could move higher as per technical analysis (ARM, S&P)
Health Department Urges DEA to Reevaluate Marijuana Restrictions (TLRY,ACB,CURLF,CGC)
Stocks in Focus as markets take a break from rallying (QQQ,NVO,ANET)
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Biotech
Page 4
Biotech
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Protalix BioTherapeutics Inc. (NYSEAMERICAN: PLX) Releases Results of BRIGHT Phase III Study of Pegunigalsidase Alfa in Fabry Disease
Kate Hudson
-
April 1, 2022
Adverum Biotechnologies Inc. (NASDAQ:ADVM) Reports unprecedented Positive Data from Cohorts 1-4 of the OPTIC Phase 1 Clinical Trial of ADVM-022
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Announces Its Focus And Progress Across Its ATTR Amyloidosis Programs
Mustang Bio Inc. (NASDAQ:MBIO) Receives Orphan Drug Designation For Its MB-207 Therapy in XSCID Treatment
TFF Pharmaceuticals Inc. (NASDAQ:TFFP) Reports the Development of the First dosing of Tacrolimus Inhalation Powder and the Safety of Voriconazole Inhalation Powder
Jaguar Health Inc. (NASDAQ:JAGX) Subsidiary Napo Pharmaceuticals Announces the Filing of...
Ward Sport
-
July 16, 2020
0
Moderna Inc‘s (NASDAQ: MRNA) Chair Noubar Afeyan Explains How They Leveraged...
Kate Hudson
-
July 15, 2022
0
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) CEO Presents Update On Mino-Lok Study At...
Kate Hudson
-
June 30, 2020
0
Greenlight Biosciences Holdings (NASDAQ: GRNA) Collaborates With Serum Institute of India,...
Gavins Felicity
-
March 25, 2022
0
Krystal Biotech Inc. (NASDAQ: KRYS) Announce Topline Data From GEM-3 VYJUVEK...
Gavins Felicity
-
December 6, 2021
0
1
...
3
4
5
...
326
Page 4 of 326
Recent Post
Sezzle (NASDAQ: SEZL) Shares Surge on Robust Q1 Earnings and Upgraded...
Kate Hudson
-
May 9, 2024
0
Sezzle Inc. (NASDAQ:SEZL) saw its stock price increase today primarily due to its strong first-quarter financial performance for 2024. The company reported...
Actinium Pharmaceuticals (ATNM): Poised for Growth? Targeted Radiotherapy Conditioning Agent Shows...
May 8, 2024
Actinium Pharmaceuticals (ATNM) Gains Momentum: Strategic KOL Call Scheduled Amid Radiopharma...
May 7, 2024
Reason why Investors need to watch Aspen Aerogels (NYSE: ASPN) recent...
May 2, 2024
CytomX Therapeutics (NASADAQ: CTMX) Revolutionizing Cancer Treatment with Groundbreaking Biologics
May 1, 2024